Acnefree Severe Terminator Maximum Strength
Loading...Acnefree Severe Terminator Maximum Strength Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For external use only.
if you are sensitive to Benzoyl Peroxide or have very sensitive skin. This product may cause irritation. If excess irritation occurs, discontinue use. Ask a doctor or pharmacist before use if you are using any topical acne drugs at the same time or right after use of this product. This may cause irritation, characterized by redness, burning, itching, peeling or possibly swelling. Mild irritation may be reduced by using the product less frequently or in a lower concentration. If irritation becomes severe, discontinue use. If irritation still continues, consult a doctor.
if excess irritation occurs.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
for the treatment of acne.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Acnefree Severe Terminator Maximum Strength Manufacturers
-
Valeant Pharmaceuticals North America Llc
![Acnefree Severe Terminator Maximum Strength (Benzoyl Peroxide) Cream [Valeant Pharmaceuticals North America Llc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Acnefree Severe Terminator Maximum Strength | Greenstone Llc
Ethosuximide is administered by the oral route. The initial dose for patients 3 to 6 years of age is one teaspoonful (250 mg) per day; for patients 6 years of age and older, 2 teaspoonfuls (500 mg) per day. The dose thereafter must be individualized according to the patient's response. Dosage should be increased by small increments. One useful method is to increase the daily dose by 250 mg every four to seven days until control is achieved with minimal side effects. Dosages exceeding 1.5 g daily, in divided doses, should be administered only under the strictest supervision of the physician. The optimal dose for most pediatric patients is 20 mg/kg/day. This dose has given average plasma levels within the accepted therapeutic range of 40 to 100 mcg/mL. Subsequent dose schedules can be based on effectiveness and plasma level determinations.
Ethosuximide may be administered in combination with other anticonvulsants when other forms of epilepsy coexist with absence (petit mal). The optimal dose for most pediatric patients is 20 mg/kg/day.
Login To Your Free Account